Target intelligence / Profile preview

CLRN1 antisense RNA 1 (CLRN1-AS1)

Target: CLRN1-AS1
Molecular classification: Non-coding RNA, Antisense RNA, Miscellaneous RNA

Overview

CLRN1 antisense RNA 1 (CLRN1-AS1) is a long non-coding RNA gene located antisense to the *Clarin 1* (CLRN1) locus. As a non-coding antisense RNA, CLRN1-AS1 does not code for a protein and is not classified among common drug targets such as receptors, enzymes, or ion channels. Its biological functions are primarily in the regulation of gene expression via RNA-RNA interactions, predominantly with the *Clarin 1* gene. There is currently no evidence associating CLRN1-AS1 directly with human disease or as a direct therapeutic target. It is also not associated with any pharmacological agents or known safety concerns as a biomarker or target[3][5]. If you require information about *Clarin 1* (the protein-coding gene), more details can be provided upon request. Otherwise, CLRN1-AS1 (ENSG00000276055) is best classified as a long non-coding antisense RNA without established roles in drug targeting or disease pathology.

Other names: CLRN1-AS1CLRN1 antisense RNA 1

Mechanism of action

Not applicable; no drugs are known to target this molecule.

Biological functions

Regulation of gene expression (by base pairing with, and potentially regulating, the *Clarin 1* gene)Other (as a lncRNA, this gene may participate in transcriptional or post-transcriptional regulation, but precise functions may be poorly defined)

Disease associations

Other (no direct association with specific diseases reported; since it regulates *Clarin 1*, which is implicated in Usher syndrome, there could be indirect roles, but this is not demonstrated)

Beyond the preview

Go deeper on CLRN1 antisense RNA 1 (CLRN1-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLRN1 antisense RNA 1 (CLRN1-AS1).

Explore the full profile